Enzo Biochem, Inc.
ENZB · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,078 | $20,288 | -$18,261 | $7,875 |
| Dep. & Amort. | $1,272 | $2,682 | $2,827 | $2,653 |
| Deferred Tax | $0 | -$5,858 | $0 | $0 |
| Stock-Based Comp. | $2,296 | $3,148 | $2,339 | $1,638 |
| Change in WC | -$8,254 | $18,558 | -$6,835 | -$4,774 |
| Other Non-Cash | $4,505 | -$75,794 | $3,340 | -$7,005 |
| Operating Cash Flow | -$26,259 | -$36,976 | -$16,590 | $387 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$545 | -$2,760 | -$3,472 | -$4,436 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $28,695 | -$30,061 |
| Inv. Sales/Matur. | $0 | $0 | $28,695 | $0 |
| Other Inv. Act. | $0 | $101,740 | -$28,695 | -$30,061 |
| Investing Cash Flow | -$545 | $98,980 | $25,223 | -$34,497 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,719 | -$1,139 | -$269 | -$339 |
| Stock Issued | $0 | $386 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$474 | -$372 | $0 | $0 |
| Financing Cash Flow | -$4,193 | -$1,125 | -$241 | -$242 |
| Forex Effect | -$5 | -$109 | -$63 | $11 |
| Net Chg. in Cash | -$31,002 | $60,770 | $8,329 | -$34,341 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83,373 | $22,603 | $14,274 | $48,615 |
| End Cash | $52,371 | $83,373 | $22,603 | $14,274 |
| Free Cash Flow | -$26,804 | -$39,736 | -$20,062 | -$4,049 |